FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509668034> ?p ?o ?g. }

• W2509668034 endingPage "8" @default.
• W2509668034 startingPage "554" @default.
• W2509668034 abstract "To explore the impact of Glivec related side effects on daily life in Chinese patients with chronic myeloid leukemia (CML) in the chronic phase (CP).From May to November in 2014, anonymous questionnaires were distributed to adult CML patients who were receiving tyrosine kinase inhibitors (TKI) treatment in China. The impact of TKI related side effects on daily life were assessed by the score of 1 (no impact) to 5 (high impact) from patient self- report.Data from 548 respondents in the CP on Glivec were collected. 303(55%) cases were male with the median age of 40 years (range, 18 to 88 years). 437 (80% ) cases started Glivec treatment within one year after diagnosis with a median treatment duration of 3 years (range, <1 to 13 years), 442 (81%) respondents achieved complete cytogenetic response (CCyR), and 261 (48% ) complete molecular response (CMR). The most common Glivec related adverse effects were edema (n=278, 51% ), fatigue (n=218, 40% ), gastrointestinal disorders (n=190, 35%), muscle cramps (n=118, 22%), skin color changes (n=118, 22%), weight gain (n=71, 13%), rash (n=60, 11%), hepatic function abnormality (n=55, 10%), and cytopenia (n=38, 7%). Among the 548 respondents, the mean score of Glivec-related side effects on daily life was 2.4±1.2. There was no negative impact of Glivec related side effects on daily life in 161(29%) respondents. 295 (54% ) and 92 (17% ) respondents reported slightly or moderately (2- 3 score) and significantly decreased (4-5 score) daily life, respectively. Multivariate analysis showed that Glivec treatment duration < 4 years (OR=1.9, 95% CI 1.3- 2.6;P<0.001) and Glivec related side effects including fatigue (OR=2.9, 95% CI 2.1-4.1;P<0.001), edema (OR=2.2, 95% CI 1.6-3.1;P<0.001), gastrointestinal disorders (OR= 2.6, 95% CI 1.9- 3.7;P<0.001), rash (OR=2.1, 95% CI 1.2- 3.4; P=0.0051) and hepatic function abnormality (OR=2.3, 95% CI 1.4-3.9;P=0.0013) were factors associated with serious negative effect on daily life.Daily life was impaired seriously in a minority of Chinese CML patients who received Glivec, especially in the first 4 years of treatment. Fatigue, edema, gastrointestinal disorders, rash and hepatic function abnormality were side effects associated with negative impact on patients' daily life." @default.
• W2509668034 created "2016-09-16" @default.
• W2509668034 creator A5007312763 @default.
• W2509668034 creator A5011029344 @default.
• W2509668034 creator A5035064408 @default.
• W2509668034 creator A5052596963 @default.
• W2509668034 date "2016-07-01" @default.
• W2509668034 modified "2023-09-27" @default.
• W2509668034 title "[The impact of Glivec related side effects on daily life in Chinese patients with chronic myeloid leukemia in the chronic phase]." @default.
• W2509668034 cites W1210836019 @default.
• W2509668034 cites W1968747503 @default.
• W2509668034 cites W1984698679 @default.
• W2509668034 cites W1998406030 @default.
• W2509668034 cites W2013450609 @default.
• W2509668034 cites W2033626048 @default.
• W2509668034 cites W2044966465 @default.
• W2509668034 cites W2062448901 @default.
• W2509668034 cites W2068508150 @default.
• W2509668034 cites W2082325045 @default.
• W2509668034 cites W2129382787 @default.
• W2509668034 cites W2143116594 @default.
• W2509668034 cites W2166270808 @default.
• W2509668034 cites W2167325977 @default.
• W2509668034 doi "https://doi.org/10.3760/cma.j.issn.0253-2727.2016.07.003" @default.
• W2509668034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7365006" @default.
• W2509668034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27535853" @default.
• W2509668034 hasPublicationYear "2016" @default.
• W2509668034 type Work @default.
• W2509668034 sameAs 2509668034 @default.
• W2509668034 citedByCount "4" @default.
• W2509668034 countsByYear W25096680342016 @default.
• W2509668034 countsByYear W25096680342017 @default.
• W2509668034 countsByYear W25096680342018 @default.
• W2509668034 countsByYear W25096680342019 @default.
• W2509668034 crossrefType "journal-article" @default.
• W2509668034 hasAuthorship W2509668034A5007312763 @default.
• W2509668034 hasAuthorship W2509668034A5011029344 @default.
• W2509668034 hasAuthorship W2509668034A5035064408 @default.
• W2509668034 hasAuthorship W2509668034A5052596963 @default.
• W2509668034 hasConcept C126322002 @default.
• W2509668034 hasConcept C1862650 @default.
• W2509668034 hasConcept C197934379 @default.
• W2509668034 hasConcept C2778570526 @default.
• W2509668034 hasConcept C2778729363 @default.
• W2509668034 hasConcept C2780007613 @default.
• W2509668034 hasConcept C2780366003 @default.
• W2509668034 hasConcept C71924100 @default.
• W2509668034 hasConcept C79544238 @default.
• W2509668034 hasConcept C90924648 @default.
• W2509668034 hasConceptScore W2509668034C126322002 @default.
• W2509668034 hasConceptScore W2509668034C1862650 @default.
• W2509668034 hasConceptScore W2509668034C197934379 @default.
• W2509668034 hasConceptScore W2509668034C2778570526 @default.
• W2509668034 hasConceptScore W2509668034C2778729363 @default.
• W2509668034 hasConceptScore W2509668034C2780007613 @default.
• W2509668034 hasConceptScore W2509668034C2780366003 @default.
• W2509668034 hasConceptScore W2509668034C71924100 @default.
• W2509668034 hasConceptScore W2509668034C79544238 @default.
• W2509668034 hasConceptScore W2509668034C90924648 @default.
• W2509668034 hasIssue "7" @default.
• W2509668034 hasLocation W25096680341 @default.
• W2509668034 hasOpenAccess W2509668034 @default.
• W2509668034 hasPrimaryLocation W25096680341 @default.
• W2509668034 hasRelatedWork W1978075178 @default.
• W2509668034 hasRelatedWork W2182627843 @default.
• W2509668034 hasRelatedWork W2269918025 @default.
• W2509668034 hasRelatedWork W2356127920 @default.
• W2509668034 hasRelatedWork W2388106736 @default.
• W2509668034 hasRelatedWork W2409837444 @default.
• W2509668034 hasRelatedWork W2410026562 @default.
• W2509668034 hasRelatedWork W2509668034 @default.
• W2509668034 hasRelatedWork W4210530322 @default.
• W2509668034 hasRelatedWork W4249623968 @default.
• W2509668034 hasVolume "37" @default.
• W2509668034 isParatext "false" @default.
• W2509668034 isRetracted "false" @default.
• W2509668034 magId "2509668034" @default.
• W2509668034 workType "article" @default.